Vir Biotechnology, Inc.VIRNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-453.65M
↓ 1440% below average
Average (7y)
$-29.46M
Historical baseline
Range
High:$1.60B
Low:$-800.36M
CAGR
+30.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-453.65M | +43.3% |
| 2023 | $-800.36M | -150.2% |
| 2022 | $1.60B | +2398.4% |
| 2021 | $-69.41M | +64.9% |
| 2020 | $-197.49M | -42.5% |
| 2019 | $-138.57M | -35.5% |
| 2018 | $-102.29M | -48.0% |
| 2017 | $-69.12M | - |